Vokkaligara Sangha Dental College and Hospital

Bangalore, India

Vokkaligara Sangha Dental College and Hospital

Bangalore, India
SEARCH FILTERS
Time filter
Source Type

Mohandas U.,Vokkaligara Sangha Dental College and Hospital
Journal of Indian Society of Pedodontics and Preventive Dentistry | Year: 2010

Dental caries comprise the single most chronic disease affecting children today. Evidence increasingly suggests that for successful prevention of dental caries, preventive interactions must begin within the first year of life. Pediatricians are responsible for the primary care of the child and are well positioned to begin this process if they recognize and encourage good preventive habits and refer appropriately. Insufficient information about their role in prevention of dental caries led us to conduct a survey among pediatricians in Bangalore urban to determine their knowledge, attitude and practice in prevention of dental caries.


Mehta D.,Vokkaligara Sangha Dental College and Hospital | Gowda V.,Vokkaligara Sangha Dental College and Hospital | Finger W.J.,Tohoku University | Sasaki K.,Tohoku University
Dental Materials | Year: 2015

Objective Hypersensitivity of non-carious cervical lesions (DH) is a frequently encountered disease. This randomized, controlled, single-blind crossover study evaluated the effectiveness of a calcium phosphate containing desensitizer paste (TAP) on DH in comparison to water as placebo (PLA). Methods In this clinical trial 35 patients were randomly assigned to the test and the negative control group. Using a 10 cm long VAS (visual analog scale) patients should respond with DH score >6 on one tooth in each of two quadrants for allocation. Pain stimuli were a 2-seconds air blast (AB) and probe scratching (PS) of the exposed dentin. VAS scores were determined pre-operatively (PRE), immediately after treatment (POST), at 1 week, 1, 3 and finally after 6 months. Results Both TAP and PLA applications decreased DH significantly at POST and throughout the 6-months recalls (p < 0.001). Pain reductions upon AB stimulation of TAP treated teeth, assessed at POST and 6 months were 35 and 55%, upon PS stimuli 21 and 54%, respectively. PLA treated lesions responded to AB at POST and after 6 months with 20 and 36% pain reduction, to PS with 11 and 30% pain reduction, respectively. Differences between TAP and PLA pain scores were statistically significant at all recalls (p < 0.05). Significance TAP paste reduced DH successfully during this 6-months trial. The calcium phosphate crystallites included in the paste and the presumed hydroxyapatite precipitates upon exposure to saliva were hypothetically able to occlude open dentinal tubules, at least to some extent. TAP is considered a biocompatible desensitizer paste. © 2015 Academy of Dental Materials.


PubMed | Tohoku University and Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: Dental materials : official publication of the Academy of Dental Materials | Year: 2015

Hypersensitivity of non-carious cervical lesions (DH) is a frequently encountered disease. This randomized, controlled, single-blind crossover study evaluated the effectiveness of a calcium phosphate containing desensitizer paste (TAP) on DH in comparison to water as placebo (PLA).In this clinical trial 35 patients were randomly assigned to the test and the negative control group. Using a 10cm long VAS (visual analog scale) patients should respond with DH score >6 on one tooth in each of two quadrants for allocation. Pain stimuli were a 2-seconds air blast (AB) and probe scratching (PS) of the exposed dentin. VAS scores were determined pre-operatively (PRE), immediately after treatment (POST), at 1 week, 1, 3 and finally after 6 months.Both TAP and PLA applications decreased DH significantly at POST and throughout the 6-months recalls (p<0.001). Pain reductions upon AB stimulation of TAP treated teeth, assessed at POST and 6 months were 35 and 55%, upon PS stimuli 21 and 54%, respectively. PLA treated lesions responded to AB at POST and after 6 months with 20 and 36% pain reduction, to PS with 11 and 30% pain reduction, respectively. Differences between TAP and PLA pain scores were statistically significant at all recalls (p<0.05).TAP paste reduced DH successfully during this 6-months trial. The calcium phosphate crystallites included in the paste and the presumed hydroxyapatite precipitates upon exposure to saliva were hypothetically able to occlude open dentinal tubules, at least to some extent. TAP is considered a biocompatible desensitizer paste.


Rajaram P.,Vokkaligara Sangha Dental College and Hospital | Bhattacharjee A.,Vokkaligara Sangha Dental College and Hospital | Ticku S.,Vokkaligara Sangha Dental College and Hospital
Journal of Clinical and Diagnostic Research | Year: 2016

Serratiopeptidase is a proteolytic enzyme that has been used for reducing inflammation, it has antiedemic, analgesic, fibrinolytic and caesinolytic properties. Serratiopeptidase is often used in oral surgery for its anti-inflammatory purpose after impaction surgery, maxillofacial trauma and infections but its use should be limited in cases of abscess due to its fibrinolytic activity. Here, we report a case of a buccal space abscess which had spread into deeper muscular layers after serratiopeptidase administration in a 32-year-old male without any systemic condition. Patient presented with a painful swelling on the right mid region of the face since seven days. Serratiopeptidase was discontinued. After routine blood investigation and ultrasonography, incision and drainage was done and the patient recovered after seven days of treatment. © 2016, Journal of Clinical and Diagnostic Research. All rights reserved.


Kadanakuppe S.,Vokkaligara Sangha Dental College and Hospital
Oral health & preventive dentistry | Year: 2013

The objective of this study was to assess the opinion of dental patients who use tobacco towards receiving tobacco cessation counseling and services in a dental college and hospital setting. A cross-sectional descriptive survey method using a structured questionnaire was used in this study. Participants were patients attending The Oxford Dental College, Hospital, and Research Center, Bengaluru, India. Each patient in the clinic waiting room was asked by the investigator to complete a 29-item self-administered questionnaire. Descriptive statistics and bivariate analysis using Fisher's exact tests were used for statistical analysis of the data. Ninety-six percent (n = 770) of tobacco users had previously attempted to quit tobacco and 95.7% were willing to quit. Sixteen percent (n = 132) of respondents reported that they currently used tobacco. About 83% of tobacco users agreed that the student dentist should ask patients whether or not they use tobacco, 79.4% agreed that the student dentist should advise tobacco users to quit, and 81.4% agreed that student dentists should offer information on quitting tobacco to patients who want to quit. Only 12.5% (n = 100) of the patients who use tobacco were aware of the community resources available to quit tobacco. This study shows that patients expect and felt comfortable with receiving tobacco cessation counseling services by oral health professionals in a dental hospital setting.


PubMed | Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: Journal of clinical and diagnostic research : JCDR | Year: 2016

Serratiopeptidase is a proteolytic enzyme that has been used for reducing inflammation, it has antiedemic, analgesic, fibrinolytic and caesinolytic properties. Serratiopeptidase is often used in oral surgery for its anti-inflammatory purpose after impaction surgery, maxillofacial trauma and infections but its use should be limited in cases of abscess due to its fibrinolytic activity. Here, we report a case of a buccal space abscess which had spread into deeper muscular layers after serratiopeptidase administration in a 32-year-old male without any systemic condition. Patient presented with a painful swelling on the right mid region of the face since seven days. Serratiopeptidase was discontinued. After routine blood investigation and ultrasonography, incision and drainage was done and the patient recovered after seven days of treatment.


PubMed | Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: Oral health & preventive dentistry | Year: 2013

The objective of this study was to assess the opinion of dental patients who use tobacco towards receiving tobacco cessation counseling and services in a dental college and hospital setting.A cross-sectional descriptive survey method using a structured questionnaire was used in this study. Participants were patients attending The Oxford Dental College, Hospital, and Research Center, Bengaluru, India. Each patient in the clinic waiting room was asked by the investigator to complete a 29-item self-administered questionnaire. Descriptive statistics and bivariate analysis using Fishers exact tests were used for statistical analysis of the data.Ninety-six percent (n = 770) of tobacco users had previously attempted to quit tobacco and 95.7% were willing to quit. Sixteen percent (n = 132) of respondents reported that they currently used tobacco. About 83% of tobacco users agreed that the student dentist should ask patients whether or not they use tobacco, 79.4% agreed that the student dentist should advise tobacco users to quit, and 81.4% agreed that student dentists should offer information on quitting tobacco to patients who want to quit. Only 12.5% (n = 100) of the patients who use tobacco were aware of the community resources available to quit tobacco.This study shows that patients expect and felt comfortable with receiving tobacco cessation counseling services by oral health professionals in a dental hospital setting.


PubMed | KLE University and Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: The Korean journal of pain | Year: 2014

Burning Mouth Syndrome (BMS) is defined as a chronic orofacial pain syndrome, without evidence of mucosal lesions and other clinical signs of disease or laboratory abnormalities. Patients with BMS complain of burning pain in the mouth, xerostomia and taste disturbances. It is more common among women and the median age of occurrence is about 60 years. BMS may be primary or secondary to other diseases. The mainstay in the treatment of BMS includes antidepressants, benzodiazepines, and anticonvulsants. A few cases of BMS caused due to medication have been reported. The causative drugs include angiotensin-converting enzyme inhibitors, anticoagulants, antipsychotics, antiretrovirals, and benzodiazepines. This is a case report of a patient on antidepressants who developed symptoms of BMS thereby causing a dilemma in management.


PubMed | Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: American journal of dentistry | Year: 2012

To evaluate the efficacy of two commercial desensitizing agents in subjects with moderate to severe dentin hypersensitivity for a period of 6 months and to compare the results with topical application of water as negative control.BisBlock (BIS; oxalate) and Gluma Desensitizer PowerGel (GLU; glutaraldehyde/HEMA) were tested. 50 subjects, average age 32.4 years, with at least one cervical hypersensitive incisor, canine or premolar tooth area and pre-operative pain score > or = 6 on VAS from 0 to 10 in each of three quadrants were included. Prior to application of the desensitizing agents or placebo (PLA; water) the sensitive areas were cleaned with prophy paste. Desensitizers were applied according to manufacturers instructions, the placebo was left for 60 seconds dwell, rinsed off and dried. Pain scores were determined using both evaporative and tactile stimuli immediately after treatment, after 1 day, 1 week, 1, 3 and 6 months. Statistical analyses of the findings were performed using ANOVA and pot-hoc tests with a significance set at P < or = 0.05.All subjects completed the trial. Both the two desensitizing agents and placebo showed significant reduction in sensitivity at baseline and throughout the 6-month evaluation. The effects of the three treatments were significantly different. Pain reduction with GLU was consistently highest, followed by PLA that was significantly greater than BIS. VAS scores for the evaporative stimulus were moderately, but significantly lower than for tactile stimulation.


PubMed | Vokkaligara Sangha Dental College and Hospital
Type: Journal Article | Journal: European journal of oral sciences | Year: 2013

The aim of this clinical trial was to compare tooth sensitivity during and after bleaching with hydrogen peroxide gel following application of GLUMA Desensitizer PowerGel or placebo. Forty-six subjects with sound maxillary incisors and canines were enrolled. Tooth shades were determined by comparison with a Vitapan Classic Shade guide. GLUMA Desensitizer PowerGel and placebo were randomly applied to the labial surfaces of the left or right anterior teeth for 1 min, which were then rinsed and dried. Then, Opalescence Boost PF 40% gel was applied onto labial enamel for 15 min. Sensitivity scores [recorded on a 10-point visual-analog scale (VAS)] were determined before, at 5, 10, and 15 min during, and 1, 24, 48 h and 1 wk after, the bleaching treatment. Shades were determined postbleaching and after 1 wk. Prebleaching application of GLUMA Desensitizer PowerGel significantly reduced tooth sensitivity during and after bleaching when compared with treatment with placebo. The whitening effects immediately and 1 wk after bleaching were significant when compared with the prebleaching shades. In conclusion, tooth pretreatment with GLUMA Desensitizer PowerGel for 1 min prior to 15 min of in-office bleaching with 40% hydrogen peroxide gel was highly effective in reducing tooth sensitivity during and after bleaching.

Loading Vokkaligara Sangha Dental College and Hospital collaborators
Loading Vokkaligara Sangha Dental College and Hospital collaborators